Navigation Links
Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology

cessful clinical trials of the company's planned products including; the ability to enroll the studies in a timely manner, patient compliance with the study protocol, and a sufficient number of patients completing the studies; the ability of the company to commercialize its planned products; the ability of the company to consummate a favorable marketing agreement with a partner to market EpiCeram(TM); market acceptance of the company's planned products, the company's ability to successfully develop its licensed compounds, alone or in cooperation with others, into commercial products, the ability of the company to successfully prosecute and protect its intellectual property, and the company's ability to hire, manage and retain qualified personnel. The aforementioned factors do not represent an all inclusive list. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained in this press release. In particular, important factors that could cause actual results to differ materially from the company's forward-looking statements include general economic factors, business strategies, the state of capital markets, regulatory conditions, and other factors not currently known to the company, may be significant, now or in the future, and these factors may affect the company to a greater extent than indicated. All forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements set forth in this press release and in other documents that the company files from time to time with the Securities and Exchange Commission including its Annual Report on Form 10-KSB for the year ended December 31, 2006, Quarterly Reports on Form 10-QSB and Current Reports on Form 8-KSB to be filed in 2007. Except as required by law, the company does not undertake any obligation to update any forward-looking statemen
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
2. Ceragenix Announces Results from Phase IV Study of EpiCeram Meet All Primary and Secondary Endpoints
3. Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm Formation in 21 Day Study
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:11/26/2014)... 26, 2014 Scott Steiger lives in ... world. As an engineer for the past 20 years, he,s traveled ... military service. He,s been to six of the seven continents. Travel ... - http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... has a pretty good idea of what,s required. His ...
(Date:11/26/2014)... A hernia is condition in which a tissue, ... of a weak muscle area. Obesity, poor nutrition, smoking, and ... causes of hernias. There are several types of hernia such ... is when part of the abdominal tissue/organ protrudes into the ... of the umbilicus. A hiatal hernia is when a portion ...
(Date:11/26/2014)... 2014  CARsgen, a leader in the development of ... a variety of cancers, today announced the completion of ... China -based healthcare private equity fund.   ... the development of new therapeutics for liver, lung, stomach ... and Shanghai Renji Hospital, the company plans to initiate ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
... 2, 2010 CSA Medical, Inc. ( www.CSAmedical.com ) ... incoming president, CEO and member of the board of ... years of medical device experience, including market development roles ... "We are thrilled to have Bill join ...
... Dec. 2, 2010 Sagent Pharmaceuticals, Inc., a ... approval of four presentations of midazolam injection, USP, ... which will be offered in latex-free vials, in ... U.S. market for injectable midazolam approximated $52 million. ...
Cached Medicine Technology:CSA Medical Appoints William H. Floyd President and CEO 2Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP 2
(Date:11/28/2014)... Now that the holiday season is here, ... nation's leading cash-for-junk-cars companies, is improving their cash offers ... competitive and help bring a little bit more joy ... year. , Along with purchasing expensive gifts for family ... deal with large travel expenses during the holiday season. ...
(Date:11/28/2014)... On Monday, November 24, 2014, just ... Feeding America Eastern Wisconsin with a check for over ... a portion of proceeds to Feeding America Eastern Wisconsin. ... 7 Ways to Save” with Turbana bananas and Fyffes ... for $4 and Turbana bananas were 29 cents per ...
(Date:11/28/2014)... 2014 Miami's Plastic Surgery of the ... founder Dr. Jeffrey Epstein is excited to ... groundbreaking WordPress platform, the site is uniquely designed for ... up to 75% of all prospective rhinoplasty patients research ... are logging on with smartphones, tablets, and laptops, as ...
(Date:11/28/2014)... November 28, 2014 Written and narrated by ... Forest Voices releases the “The Happiest Man In the ... compelling account of how and why Project C.U.R.E. came to ... his mother Josie and the Reverend Richard W. Jackson, Dr. ... age of 30, but realized that he wasn’t happy. Prompted ...
(Date:11/28/2014)... Not only is the Éminence Organic Skin Care ... and other cancer-causing agents, but they are also proud ... programs that help in the fight against breast cancer. ... incredible, record-breaking contribution of $30,000 through participation in the ... Red Rose Whip Moisturizer and the company’s corporate donation. ...
Breaking Medicine News(10 mins):Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners With Sendik's Food Market to Donate $11,500 to Local Hunger-Relief Non-Profit 3Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3
... 2011 A large cohort study following 37,000 teenagers for ... Mass Index (BMI) constitutes a substantial risk factor for obesity-related ... showed that elevated BMI in adolescence has distinctive relationships with ... Researchers showed that diabetes is influenced mainly ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, April ... HIV-prevention research, a new study of heterosexual couples confirms ... of the virus in semen and cervical fluid. ... of transmission -- hasn,t been proven to this extent before, ...
... By Maureen Salamon HealthDay Reporter , ... little-known critical illness known as acute respiratory distress syndrome ... recovering, despite the fact that their lungs heal almost ... patients -- 86 percent of whom participated in a ...
... Education, Criminal Justice, and Human Services (CECH) will ... beginning at 8 a.m., Saturday, April 16, at ... will feature research presentations from graduate students representing ... of Louisville. The conference provides graduate-level students ...
... Neuralstem, Inc. (NYSE Amex: CUR) announced that the Phase ... cells (HSSCs) in amyotrophic lateral sclerosis (ALS or Lou ... the American Academy of Neurology (AAN) Annual Meeting, April ... these will be a presentation by Eva Feldman, M.D., ...
... breast cancer treatment and research including innovations in ... discussed Friday, April 8, 2011, at a breast cancer ... Philadelphia. The all-day, breast cancer symposium, part of ... be held at the Bluemle Life Sciences Building, 233 ...
Cached Medicine News:Health News:Adolescent body mass index can predict young adulthood diabetes and heart disease 2Health News:Adolescent body mass index can predict young adulthood diabetes and heart disease 3Health News:Amount of HIV in Genital Fluid Linked to Transmission 2Health News:Years Later, Victims of Critical Respiratory Illness Still Suffer 2Health News:Years Later, Victims of Critical Respiratory Illness Still Suffer 3Health News:Conference highlights graduate student research in education, health and criminal justice 2Health News:Conference highlights graduate student research in education, health and criminal justice 3Health News:Conference highlights graduate student research in education, health and criminal justice 4Health News:Conference highlights graduate student research in education, health and criminal justice 5Health News:Neuralstem ALS trial in multiple presentations at upcoming American Academy of Neurology meeting 2Health News:Neuralstem ALS trial in multiple presentations at upcoming American Academy of Neurology meeting 3Health News:Kimmel Cancer Center at Jefferson breast cancer symposium features latest in research, treatment 2
... selectively removes closures from various sample tubes with ... rack opening in one run. The Decapping Module ... like Sorting System RS 800 (optional), Sorting System ... Aliquoting System RSD 800A. All common primary tubes ...
... Detection Reagents provide molecular labs a more ... By using our MGB technology, combined with ... now able to provide molecular labs more ... of specific organisms or genetic mutations associated ...
... molecular labs a more advanced alternative for ... MGB technology, combined with post-PCR dissociation melt ... provide molecular labs more powerful tools for ... or genetic mutations associated with disease, as ...
... the latest and most advanced fecal occult ... line. An immunochemical FOBT (iFOBT) with high ... proven to detect bleeding associated with more ... Because of its superior specificity for lower ...
Medicine Products: